Annual Report 10-11 - Elder Pharmaceuticals Ltd.

28 th Annual Report2010 - 11Company OverviewStrategic ReviewBoard and Management ReportsFINANCIAL STATEMENTSxviii. Borrowing Costs : that asset, up to the date such assets are ready for their intended use. xix. Taxation: xx. Provisions and Contingent Liabilities:Iis remote, no provision or disclosure is required.2. CONTINGENT LIABILITIESAs at31st March 2011(` in Lacs)As at31st March 2010(` in Lacs)a) Letters of Credit 3242.89 2933.74 Bank Guarantees 342.55 180.39c) 8673.47 --d) i) Income tax* 268.58 73.79ii) Sales tax 17.56 17.56iii) Customs Duty 25.00 49.50iv) Excise Duty -- 12.55* Includes demand of ` 216.53/- lacsTax Department3. 1869.96 1906.21Capital Account and not provided for.4. Deferred Tax:A) i) Depreciation 1435.84 1372.11B) Deferred Tax Asset:i) Leave encashment 142.47 159.96ii) Others 945.21 830.831087.68 990.79 348.16 381.3293